Metropolis Healthcare Allots 15,54,95,826 Bonus Shares in 3:1 Ratio

1 min read     Updated on 23 Mar 2026, 08:03 AM
scanx
Reviewed by
Radhika SScanX News Team
Overview

Metropolis Healthcare Limited successfully completed its bonus share allotment on March 23, 2026, issuing 15,54,95,826 new equity shares in a 3:1 ratio to eligible shareholders as of record date March 20, 2026. The allotment increased the company's paid-up share capital to INR 41,46,55,536/- comprising 20,73,27,768 equity shares of INR 2/- face value each. The corporate action was conducted under SEBI regulations and formally communicated to BSE and NSE.

35778838

*this image is generated using AI for illustrative purposes only.

Metropolis Healthcare Limited has completed the allotment of bonus equity shares on March 23, 2026, issuing 15,54,95,826 new equity shares to eligible shareholders. The bonus issue was executed in a 3:1 ratio, providing three new fully paid-up equity shares for every existing share held by shareholders whose names appeared in the company's records as of March 20, 2026.

Bonus Share Allotment Details

The healthcare diagnostics company allotted the bonus shares with a face value of INR 2/- each as fully paid equity shares. The allotment was made to eligible members whose names appeared in the Register of Members or Register of Beneficial Owners as on the record date of March 20, 2026.

Parameter: Details
Allotment Date: March 23, 2026
Record Date: March 20, 2026
Bonus Ratio: 3:1
New Shares Issued: 15,54,95,826
Face Value per Share: INR 2/-

Impact on Share Capital Structure

Following the bonus share allotment, Metropolis Healthcare's capital structure has undergone significant changes. The paid-up share capital has increased substantially from the pre-bonus levels.

Metric: Post-Allotment
Total Paid-up Share Capital: INR 41,46,55,536/-
Total Number of Equity Shares: 20,73,27,768
Face Value per Share: INR 2/-

Regulatory Compliance

The bonus share allotment was conducted pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company had previously informed the stock exchanges through intimations dated February 04, 2026, March 09, 2026, and March 10, 2026, regarding the bonus issue process.

Stock Exchange Communication

Metropolis Healthcare formally communicated the completion of the bonus share allotment to both BSE Limited (Scrip Code: 542650) and National Stock Exchange of India Ltd. (Scrip Symbol: METROPOLIS) on March 23, 2026. The communication was signed by Kamlesh C Kulkarni, Head – Legal & Secretarial, confirming the successful completion of the corporate action.

The bonus issue represents a significant corporate action for the diagnostic services company, effectively quadrupling the number of shares held by existing shareholders while maintaining their proportionate ownership in the company.

Historical Stock Returns for Metropolis Healthcare

1 Day5 Days1 Month6 Months1 Year5 Years
+2.06%-0.43%-3.19%-15.60%+12.43%-8.74%
like19
dislike

Metropolis Healthcare schedules analyst meeting with Kotak Securities for March 25, 2026

1 min read     Updated on 20 Mar 2026, 07:36 PM
scanx
Reviewed by
Radhika SScanX News Team
Overview

Metropolis Healthcare Limited has scheduled an analyst and institutional investor meeting for March 25, 2026, at 3:00 p.m. IST with Kotak Securities. The company informed stock exchanges about this group meeting under SEBI regulations, emphasizing that discussions will be based on publicly available information only. The meeting details are available on the company's website, with potential schedule changes noted due to participant or company exigencies.

35561165

*this image is generated using AI for illustrative purposes only.

Metropolis Healthcare Limited has announced an analyst and institutional investor meeting scheduled for March 25, 2026, in compliance with SEBI regulations. The company informed both BSE Limited and National Stock Exchange of India about this upcoming interaction through an official communication dated March 20, 2026.

Meeting Details

The scheduled meeting details are structured as follows:

Parameter: Details
Date: March 25, 2026
Time: 03:00 p.m. (IST) onwards
Host: Kotak Securities
Type: Group Meeting

Regulatory Compliance

The announcement was made pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has emphasized that discussions during the meeting will be based exclusively on publicly available information. No unpublished price sensitive information (UPSI) is intended to be discussed during the interaction.

Important Considerations

Metropolis Healthcare has noted that changes to the meeting schedule may occur due to exigencies on the part of participants, host, or the company itself. The intimation has been made available on the company's official website at www.metropolisindia.com for stakeholder reference.

The communication was signed by Kamlesh C Kulkarni, Head – Legal & Secretarial, representing Metropolis Healthcare Limited in his official capacity.

Historical Stock Returns for Metropolis Healthcare

1 Day5 Days1 Month6 Months1 Year5 Years
+2.06%-0.43%-3.19%-15.60%+12.43%-8.74%
like19
dislike

More News on Metropolis Healthcare

1 Year Returns:+12.43%